Search

Richard E. Chilcot

Examiner (ID: 8774, Phone: (571)272-6777 , Office: P/2916 )

Most Active Art Unit
2916
Art Unit(s)
1804, 2167, 2855, 2616, 3621, 3635, 3627, 3504, 2916, 2899, 2214, 3634, 2910
Total Applications
3224
Issued Applications
2808
Pending Applications
24
Abandoned Applications
392

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6249490 [patent_doc_number] => 20100137434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/583598 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14503 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137434.pdf [firstpage_image] =>[orig_patent_app_number] => 12583598 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/583598
Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer Aug 20, 2009 Issued
Array ( [id] => 6374762 [patent_doc_number] => 20100075950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'PHENYLPROPANONE MODULATORS OF DOPAMINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/544194 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11495 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075950.pdf [firstpage_image] =>[orig_patent_app_number] => 12544194 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/544194
PHENYLPROPANONE MODULATORS OF DOPAMINE RECEPTOR Aug 18, 2009 Abandoned
Array ( [id] => 5398335 [patent_doc_number] => 20090318398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION' [patent_app_type] => utility [patent_app_number] => 12/543541 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 55472 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318398.pdf [firstpage_image] =>[orig_patent_app_number] => 12543541 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/543541
ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION Aug 18, 2009 Abandoned
Array ( [id] => 6637693 [patent_doc_number] => 20100035925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AN DMETHODS FOR INHIBITING HIV INFECTIVITY' [patent_app_type] => utility [patent_app_number] => 12/539741 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 1733 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035925.pdf [firstpage_image] =>[orig_patent_app_number] => 12539741 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/539741
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AN DMETHODS FOR INHIBITING HIV INFECTIVITY Aug 11, 2009 Abandoned
Array ( [id] => 6084301 [patent_doc_number] => 20110144156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'A3 ADENOSINE RECEPTOR ALLOSTERIC MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/059836 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15097 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144156.pdf [firstpage_image] =>[orig_patent_app_number] => 13059836 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/059836
A3 ADENOSINE RECEPTOR ALLOSTERIC MODULATORS Aug 11, 2009 Abandoned
Array ( [id] => 5490868 [patent_doc_number] => 20090291939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking' [patent_app_type] => utility [patent_app_number] => 12/536143 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4981 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291939.pdf [firstpage_image] =>[orig_patent_app_number] => 12536143 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/536143
Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking Aug 4, 2009 Abandoned
Array ( [id] => 7490206 [patent_doc_number] => 20110237538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/057654 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49931 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237538.pdf [firstpage_image] =>[orig_patent_app_number] => 13057654 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/057654
TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DISEASES Aug 3, 2009 Abandoned
Array ( [id] => 9140340 [patent_doc_number] => 08580801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Phosphodiesterase inhibitor treatment' [patent_app_type] => utility [patent_app_number] => 12/508530 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21912 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12508530 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/508530
Phosphodiesterase inhibitor treatment Jul 22, 2009 Issued
Array ( [id] => 4486511 [patent_doc_number] => 07884093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Progesterone for the treatment or prevention of spontaneous preterm birth' [patent_app_type] => utility [patent_app_number] => 12/497879 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 10801 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884093.pdf [firstpage_image] =>[orig_patent_app_number] => 12497879 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/497879
Progesterone for the treatment or prevention of spontaneous preterm birth Jul 5, 2009 Issued
Array ( [id] => 6163379 [patent_doc_number] => 20110160256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'INHIBITORS OF AKT ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/000238 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14214 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160256.pdf [firstpage_image] =>[orig_patent_app_number] => 13000238 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/000238
INHIBITORS OF AKT ACTIVITY Jun 23, 2009 Abandoned
Array ( [id] => 6163378 [patent_doc_number] => 20110160255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'INHIBITORS OF AKT ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/000232 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13898 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160255.pdf [firstpage_image] =>[orig_patent_app_number] => 13000232 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/000232
INHIBITORS OF AKT ACTIVITY Jun 23, 2009 Abandoned
Array ( [id] => 5959608 [patent_doc_number] => 20110183995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'ELTOPRAZINE FOR SUPPRESSION OF L-DOPA INDUCED DYSKINESIAS' [patent_app_type] => utility [patent_app_number] => 13/001058 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5530 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183995.pdf [firstpage_image] =>[orig_patent_app_number] => 13001058 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/001058
ELTOPRAZINE FOR SUPPRESSION OF L-DOPA INDUCED DYSKINESIAS Jun 22, 2009 Abandoned
Array ( [id] => 9250452 [patent_doc_number] => 08614231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Immunosuppressor based on the blockage of TCR-Nck interaction' [patent_app_type] => utility [patent_app_number] => 13/001914 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 4065 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13001914 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/001914
Immunosuppressor based on the blockage of TCR-Nck interaction Jun 17, 2009 Issued
Array ( [id] => 8140837 [patent_doc_number] => 20120094974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'SMOOTHENED RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/737044 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 2200 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094974.pdf [firstpage_image] =>[orig_patent_app_number] => 12737044 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/737044
SMOOTHENED RECEPTOR MODULATORS Jun 15, 2009 Abandoned
Array ( [id] => 5570287 [patent_doc_number] => 20090253665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'METHOD OF TREATMENT OF DISEASE USING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/485797 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4507 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253665.pdf [firstpage_image] =>[orig_patent_app_number] => 12485797 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/485797
METHOD OF TREATMENT OF DISEASE USING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR Jun 15, 2009 Abandoned
Array ( [id] => 6186769 [patent_doc_number] => 20110124727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation' [patent_app_type] => utility [patent_app_number] => 12/999195 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3477 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124727.pdf [firstpage_image] =>[orig_patent_app_number] => 12999195 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/999195
Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation Jun 11, 2009 Abandoned
Array ( [id] => 6039497 [patent_doc_number] => 20110092546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'SUBSTITUTED BENZIMIDAZOLES FOR NEUROFIBROMATOSIS' [patent_app_type] => utility [patent_app_number] => 12/997770 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9342 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092546.pdf [firstpage_image] =>[orig_patent_app_number] => 12997770 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/997770
SUBSTITUTED BENZIMIDAZOLES FOR NEUROFIBROMATOSIS Jun 10, 2009 Abandoned
Array ( [id] => 6048785 [patent_doc_number] => 20110207793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => '1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS.' [patent_app_type] => utility [patent_app_number] => 12/737092 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10367 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207793.pdf [firstpage_image] =>[orig_patent_app_number] => 12737092 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/737092
1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS. Jun 9, 2009 Abandoned
Array ( [id] => 5465815 [patent_doc_number] => 20090326015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'COMPOUNDS WITH EMBEDDED BENZOPYRAN MOTIF FOR CORE STRUCTURES AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/481137 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17482 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326015.pdf [firstpage_image] =>[orig_patent_app_number] => 12481137 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/481137
Compounds with embedded benzopyran motif for core structures and preparation method thereof Jun 8, 2009 Issued
Array ( [id] => 5404469 [patent_doc_number] => 20090239783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'SYNERGISTIC EFFECTS OF COMBINED ADMINISTRATION OF MIRTAZAPINE AND A STIMULANT COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/479340 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4924 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239783.pdf [firstpage_image] =>[orig_patent_app_number] => 12479340 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/479340
SYNERGISTIC EFFECTS OF COMBINED ADMINISTRATION OF MIRTAZAPINE AND A STIMULANT COMPOUND Jun 4, 2009 Abandoned
Menu